Literature DB >> 1466148

Muscarinic receptor subtypes in equine tracheal smooth muscle.

M Yu1, N E Robinson, Z Wang, F J Derksen.   

Abstract

Selective muscarinic receptor antagonists were used to identify muscarinic receptor subtypes in equine trachealis strips. The M1 receptor antagonist pirenzepine (10(-7) mol/L to 3 x 10(-5) mol/L) and the M3 receptor antagonist 4-diphenylacetoxy-N-methylpiperidine (4-DAMP, 10(-9) mol/L to 3 x 10(-7) mol/L3) dose dependently inhibited the contractile responses to electrical field stimulation (EFS) and exogenous acetylcholine (ACh). Schild plots yielded a pA2 value for pirenzepine vs ACh of 6.75 +/- 0.09, which is consistent with the affinity for M2 or M3 receptors, and a pA2 value for 4-DAMP vs ACh of 8.47 +/- 0.09, which is in agreement with the affinity for M3 receptors. The M2 receptor antagonist gallamine (10(-5) mol/L and 10(-4) mol/L) did not affect the response of trachealis to exogenous ACh and low-frequency EFS (0.1-2 Hz) but decreased the responses to high-frequency EFS (4-16 Hz). These results suggest that the muscarinic receptors mediating contractions induced by ACh in equine tracheal smooth muscle are of the M3 subtype. The lack of an increase in the response to EFS following gallamine suggests that functional prejunctional inhibitory M2 receptors are not present on the cholinergic nerves innervating equine tracheal smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466148     DOI: 10.1007/bf01839329

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  20 in total

1.  Prejunctional muscarinic receptors on cholinergic nerves in guinea pig airways are of the M2 subtype.

Authors:  C J Doelman; R C Sprong; J E Nagtegaal; J F Rodrigues de Miranda; A Bast
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

Review 2.  Muscarinic receptor subtypes in lung. Clinical implications.

Authors:  P A Minette; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1990-03

3.  Ligand binding and G protein coupling of muscarinic receptors in airway smooth muscle.

Authors:  P A Lucchesi; C R Scheid; F D Romano; M E Kargacin; D Mullikin-Kilpatrick; H Yamaguchi; T W Honeyman
Journal:  Am J Physiol       Date:  1990-04

4.  A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects.

Authors:  P A Minette; J W Lammers; C M Dixon; M T McCusker; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1989-12

5.  Muscarinic receptor subtypes in canine trachea.

Authors:  J F Brichant; D O Warner; S J Gunst; K Rehder
Journal:  Am J Physiol       Date:  1990-06

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  Evidence for prejunctional M2 muscarinic receptors in pulmonary cholinergic nerves in the rat.

Authors:  P Aas; J Maclagan
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

8.  Postganglionic muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig.

Authors:  D Faulkner; A D Fryer; J Maclagan
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

9.  Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways.

Authors:  P A Minette; P J Barnes
Journal:  J Appl Physiol (1985)       Date:  1988-06

10.  Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle.

Authors:  L C Blaber; A D Fryer; J Maclagan
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

View more
  2 in total

1.  Segment-dependent expression of muscarinic acetylcholine receptors and G-protein coupling in the equine respiratory tract.

Authors:  G Abraham; C Kottke; H Ammer; S Dhein; F R Ungemach
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

2.  Muscarinic receptors in equine airways.

Authors:  K Törneke; C Ingvast-Larsson; A Boström; L E Appelgren
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.